Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling

Abstract

Head and neck paragangliomas, rare neoplasms of the paraganglia composed of nests of neurosecretory and glial cells embedded in vascular stroma, provide a remarkable example of organoid tumor architecture. To identify genes and pathways commonly deregulated in head and neck paraganglioma, we integrated high-density genome-wide copy number variation (CNV) analysis with microRNA and immunomorphological studies. Gene-centric CNV analysis of 24 cases identified a list of 104 genes most significantly targeted by tumor-associated alterations. The “NOTCH signaling pathway” was the most significantly enriched term in the list (P = 0.002 after Bonferroni or Benjamini correction). Expression of the relevant NOTCH pathway proteins in sustentacular (glial), chief (neuroendocrine) and endothelial cells was confirmed by immunohistochemistry in 47 head and neck paraganglioma cases. There were no relationships between level and pattern of NOTCH1/JAG2 protein expression and germline mutation status in the SDH genes, implicated in paraganglioma predisposition, or the presence/absence of immunostaining for SDHB, a surrogate marker of SDH mutations. Interestingly, NOTCH upregulation was observed also in cases with no evidence of CNVs at NOTCH signaling genes, suggesting altered epigenetic modulation of this pathway. To address this issue we performed microarray-based microRNA expression analyses. Notably 5 microRNAs (miR-200a,b,c and miR-34b,c), including those most downregulated in the tumors, correlated to NOTCH signaling and directly targeted NOTCH1 in in vitro experiments using SH-SY5Y neuroblastoma cells. Furthermore, lentiviral transduction of miR-200s and miR-34s in patient-derived primary tympano-jugular paraganglioma cell cultures was associated with NOTCH1 downregulation and increased levels of markers of cell toxicity and cell death. Taken together, our results provide an integrated view of common molecular alterations associated with head and neck paraganglioma and reveal an essential role of NOTCH pathway deregulation in this tumor type.Electronic supplementary materialThe online version of this article (doi:10.1007/s00401-013-1165-y) contains supplementary material, which is available to authorized users.

TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation

“…Biological process analysis revealed that these 77 genes, activated by both TRIM28 and EZH2, share GO functions of cell projection, morphogenesis and development that are associated with stem cells and metastasis (Figure 2e and Supplementary Table S7). Examination of breast cancer patient data, available for 65 of the 77 TRIM28/EZH2-activated genes, show that altered expression of the 65 co-activated genes, 62 of which exhibit gene amplification, 30–32 is correlated with a poor probability of overall survival for breast cancer patients with invasive carcinomas (Figure 2f). …”

Effects of PPARα inhibition in head and neck paraganglioma cells

“…Primary HNPGL cell cultures were established as previously described [6] from two prospectively sampled tympano-jugular HNPGL patients (PTJ64 and PTJ86) carrying the SDHC c.43C>T (p. Arg15*) and SDHD c. 27delC (p. Val10Phefs*5) mutations, respectively. For mutational analysis the coding regions and exon–intron boundaries of SDHB , SDHC and SDHD genes were amplified by PCR as previously described [6, 21, 22].…”

“…For mutational analysis the coding regions and exon–intron boundaries of SDHB , SDHC and SDHD genes were amplified by PCR as previously described [6, 21, 22]. PCR products were subjected to 2% agarose gel electrophoresis with ethidium bromide staining and subsequently sequenced using a genetic analyzer (ABI PRISM 310; Applied Biosystems, Milan, Italy).…”

“…However, little is known about the effects of molecules with therapeutic potential in HNPGLs, also due to the lack of commercially available cell lines for this rare tumor. In a previous study we developed a primary human HNPGL cell culture and showed that lentiviral expression of tumor suppressor miRNAs downregulated in those cells was associated with apoptosis activation and cytotoxicity [6]. …”

The Role of Wait-and-Scan and the Efficacy of Radiotherapy in the Treatment of Temporal Bone Paragangliomas

“…We recently demonstrated that NOTCH signaling, a fundamental molecular pathway implicated in stem cells maintenance, organogenesis, and carcinogenesis, is commonly activated in head and neck paragangliomas (47). This could have therapeutic implications because it has been shown that NOTCH signaling promotes radioresistance in glioma cells (48).…”